Klinik und Poliklinik für Innere Medizin II, Klinikum der Universität Regensburg, Regensburg, Germany.
Eur J Heart Fail. 2013 Aug;15(8):859-67. doi: 10.1093/eurjhf/hft048. Epub 2013 Apr 7.
The natriuretic peptides BNP and NT-proBNP are potent cardiac markers, but knowledge of long-term changes is sparse. We thus quantified determinants of change in BNP and NT-proBNP in a study of south German residents (KORA).
A total of 1005 men and women (age 25-74 years, mean 48 years) underwent physical examination and echocardiography at baseline and at follow-up after 10 years. The current analysis comprised 877 subjects with dual measurements of BNP and NT-proBNP. Both markers increased in both sexes (P < 0.001) during the 10-year follow-up, and higher levels in women persisted across time (P for sex difference <0.001). Among baseline covariates, predictors for 10-year change of NT-proBNP, BNP, or both were age, sex, diabetes status, and heart rate (multivariable regression analysis, each P < 0.05). However, changes of covariates over the 10-year follow-up were much stronger determinants. Specifically, incident myocardial infarction, new beta-blocker medication, and increased cardiac parameters (left atrial diameter, LV end-diastolic diameter, and LV mass index) were associated with increasing BNP, NT-proBNP, or both, whereas increased heart rate, haematocrit, and body mass index (BMI) were associated with decreasing BNP and NT-proBNP (all P < 0.05).
Next to ageing and sex, a variety of changes in covariates reflecting the sequelae of cardiac remodelling as well as myocardial infarction and diabetes influence long-term changes of BNP and NT-proBNP. Of note, diabetes and increased BMI exert opposite effects. For interpretation of individual marker concentrations, a host of covariates needs to be considered, especially in subjects without prevalent or incident cardiac disease.
利钠肽 BNP 和 NT-proBNP 是强有力的心脏标志物,但关于其长期变化的知识还很有限。因此,我们在德国南部居民(KORA)的一项研究中定量评估了 BNP 和 NT-proBNP 变化的决定因素。
共有 1005 名年龄在 25-74 岁(平均 48 岁)的男性和女性接受了基线检查和超声心动图检查,并在 10 年后进行了随访。当前分析包括了 877 名有 BNP 和 NT-proBNP 双重测量值的受试者。在 10 年的随访过程中,两种标志物在男女中均升高(P<0.001),女性的水平在整个时间过程中持续升高(性别差异 P<0.001)。在基线协变量中,NT-proBNP、BNP 或两者的 10 年变化的预测因素为年龄、性别、糖尿病状态和心率(多元回归分析,P<0.05)。然而,10 年随访过程中协变量的变化是更强的决定因素。具体而言,新发心肌梗死、新的β受体阻滞剂治疗和心脏参数(左心房直径、LV 舒张末期直径和 LV 质量指数)的增加与 BNP、NT-proBNP 或两者的增加相关,而心率、红细胞压积和体重指数(BMI)的增加与 BNP 和 NT-proBNP 的减少相关(均 P<0.05)。
除了年龄和性别外,反映心脏重构以及心肌梗死和糖尿病后果的各种协变量的变化也会影响 BNP 和 NT-proBNP 的长期变化。值得注意的是,糖尿病和 BMI 的增加会产生相反的影响。对于个体标志物浓度的解释,需要考虑多种协变量,特别是在没有现有或新发心脏疾病的患者中。